We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

557 hedge funds and large institutions have $2.28B invested in iShares US Medical Devices ETF in 2023 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 124 increasing their positions, 264 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

173% more call options, than puts

Call options by funds: $13.1M | Put options by funds: $4.8M

1.65% more ownership

Funds ownership: 36.43%38.08% (+1.6%)

5% less first-time investments, than exits

New positions opened: 58 | Existing positions closed: 61

3% less funds holding

Funds holding: 577557 (-20)

6% less funds holding in top 10

Funds holding in top 10: 1615 (-1)

17% less capital invested

Capital invested by funds: $2.75B → $2.28B (-$472M)

53% less repeat investments, than reductions

Existing positions increased: 124 | Existing positions reduced: 264

Holders
557
Holders Change
-20
Holders Change %
-3.47%
% of All Funds
8.88%
Holding in Top 10
15
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-6.25%
% of All Funds
0.24%
New
58
Increased
124
Reduced
264
Closed
61
Calls
$13.1M
Puts
$4.8M
Net Calls
+$8.32M
Net Calls Change
+$41.6M
Name Holding Trade Value Shares
Change
Change in
Stake
WA
151
WESPAC Advisors
California
$1.82M +$365K +6,862 +26%
CWM
152
Concentrum Wealth Management
California
$1.8M +$14.3K +269 +0.8%
GPA
153
Garrison Point Advisors
California
$1.8M +$799 +15 +0%
CWM
154
C2C Wealth Management
Arizona
$1.77M
IAN
155
Integrated Advisors Network
Texas
$1.74M -$97.3K -1,828 -5%
IWM
156
IHT Wealth Management
Illinois
$1.71M -$19.3K -363 -1%
VFM
157
Valley Financial Management
New York
$1.66M +$491K +9,218 +43%
TCMP
158
Thrive Capital Management (Pennsylvania)
Pennsylvania
$1.64M -$54.9K -1,031 -3%
CBFP
159
Cedar Brook Financial Partners
Ohio
$1.63M +$46.5K +873 +3%
VF
160
Virtu Financial
New York
$1.62M -$645K -12,116 -29%
YAVAPFMC
161
Yahav Achim Ve Achayot - Provident Funds Management Company
Israel
$1.62M
AFP
162
Ausdal Financial Partners
Iowa
$1.61M -$852 -16 -0.1%
CW
163
CIC Wealth
Maryland
$1.6M -$11.6K -218 -0.7%
IFWM
164
Institute for Wealth Management
Colorado
$1.58M -$8.41K -158 -0.5%
SHJ
165
Sharkey, Howes & Javer
Colorado
$1.56M +$147K +2,765 +11%
MA
166
Mutual Advisors
Nebraska
$1.51M -$352K -6,621 -19%
MAP
167
Milestone Advisory Partners
North Carolina
$1.49M +$264K +4,963 +22%
NL
168
NWAM LLC
Washington
$1.48M -$31.5K -591 -2%
ASN
169
Advisory Services Network
Georgia
$1.47M -$167K -3,135 -10%
Jane Street
170
Jane Street
New York
$1.44M +$287K +5,382 +25%
National Bank of Canada
171
National Bank of Canada
Quebec, Canada
$1.44M +$65.5K +1,231 +5%
JPLA
172
Joseph P. Lucia & Associates
New York
$1.39M -$248K -4,652 -15%
BCM
173
Brookstone Capital Management
Illinois
$1.39M -$1.33K -25 -0.1%
PWA
174
Primoris Wealth Advisors
Florida
$1.39M
AIC
175
Ayalon Insurance Company
Israel
$1.38M

IHI Hedge Fund Activity: Q1 2023 in Review

557 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q1 2023, worth a combined $2.28B — down 17% from $2.75B a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of IHI and 58 opened new positions — a net loss of 3 holders — while 264 trimmed existing stakes and 124 added.

The largest buyer was Menora Mivtachim Holdings, opening a new position worth an estimated $105M. The largest seller was AssetMark Inc, cutting an estimated $68.6M.

  • 557 institutional investors held iShares US Medical Devices ETF (IHI) as of Q1 2023, down from 577 in Q4 2022.
  • Funds reported $2.28B of iShares US Medical Devices ETF stock for Q1 2023, down 17% quarter-over-quarter.
  • 58 funds opened new iShares US Medical Devices ETF positions in Q1 2023 and 61 closed out, a net change of -3 holders.
  • The largest iShares US Medical Devices ETF buyer in Q1 2023 was Menora Mivtachim Holdings, an estimated $105M added.
  • The largest iShares US Medical Devices ETF seller in Q1 2023 was AssetMark Inc, an estimated $68.6M sold.

Based on aggregated 13F filings for Q1 2023.